CB1 cannabinoid receptor ligands augment the antidepressant‐like activity of biometals (magnesium and zinc) in the behavioural tests. (30th January 2018)
- Record Type:
- Journal Article
- Title:
- CB1 cannabinoid receptor ligands augment the antidepressant‐like activity of biometals (magnesium and zinc) in the behavioural tests. (30th January 2018)
- Main Title:
- CB1 cannabinoid receptor ligands augment the antidepressant‐like activity of biometals (magnesium and zinc) in the behavioural tests
- Authors:
- Wośko, Sylwia
Serefko, Anna
Szopa, Aleksandra
Wlaź, Piotr
Wróbel, Andrzej
Wlaź, Aleksandra
Górska, Jolanta
Poleszak, Ewa - Abstract:
- Abstract: Objective: During the last few decades, endocannabinoid system has emerged as a novel possible target for antidepressant treatment. Although the medical literature provides information on the mood‐changing effects of CB1 ligands, little is known about the possible interaction between the simultaneous activation or inhibition of the CB1 receptor and administration of other agents that possess antidepressant potential. The main goal of our study was to evaluate the influence of the CB1 cannabinoid receptor ligands (oleamide – an endogenous agonist and AM251 – an inverse agonist/antagonist) on the antidepressant‐like activity of biometals (i.e. magnesium and zinc). Methods: The forced swim test and the tail suspension test in mice were used to determine the antidepressant‐like activity. Key findings: Concomitant intraperitoneal administration of per se inactive doses of oleamide (5 mg/kg) or AM251 (0.25 mg/kg) and the tested biometals (i.e. magnesium, 10 mg/kg or zinc, 5 mg/kg) shortened the immobility time of animals in the forced swim test and the tail suspension test. The observed effect was not associated with an increase in spontaneous locomotor activity of mice. Conclusions: The simultaneous modulation of the cannabinoid system and supplementation of magnesium or zinc produce at least additive antidepressant‐like effect.
- Is Part Of:
- Journal of pharmacy and pharmacology. Volume 70:Number 4(2018)
- Journal:
- Journal of pharmacy and pharmacology
- Issue:
- Volume 70:Number 4(2018)
- Issue Display:
- Volume 70, Issue 4 (2018)
- Year:
- 2018
- Volume:
- 70
- Issue:
- 4
- Issue Sort Value:
- 2018-0070-0004-0000
- Page Start:
- 566
- Page End:
- 575
- Publication Date:
- 2018-01-30
- Subjects:
- AM251 -- forced swim test -- magnesium -- oleamide -- tail suspension test -- zinc
Pharmacy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- https://academic.oup.com/jpp ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2042-7158 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.ingentaconnect.com/content/rpsgb/jpp ↗ - DOI:
- 10.1111/jphp.12880 ↗
- Languages:
- English
- ISSNs:
- 0022-3573
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5034.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6173.xml